Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

39.35 -0.18 (-0.46%)

Delayed Quote Updated: 10:34 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

35 36 Next >

Cramer Says This Major Healthcare Stock Is 'Ridiculously Cheap And Doing So Many Great Things' ↗

January 08, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Realty Income (NYSE: O) and recommends staying with it. "It’s a very steady story," he noted.

Via Benzinga

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024

January 02, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference

December 28, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

My 5 Largest Portfolio Holdings for 2024 ↗

December 15, 2023

This mix of growth and value stocks appears set to outperform -- and hopefully makes me a lot richer in the process.

Via The Motley Fool

What To Know About UBS's Upgrade of Teva Pharmaceutical Indus ↗

November 27, 2023

Via Benzinga

Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma

December 14, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity

December 06, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Venue Turmoil: Pharma Companies Oppose States' Bid to Relocate Price-Fixing Cases ↗

December 04, 2023

Major pharmaceutical firms, including generic manufacturers such as Teva Pharmaceutical Industries Limited (NYSE: TEVA), Sandoz Group (OTC:

Via Benzinga

Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity ↗

December 03, 2023

The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in th

Via Benzinga

Topics Bankruptcy

MarketBeat Week in Review – 11/27 - 12/1

December 02, 2023

Stocks closed the week at or near yearly highs after subdued inflation numbers suggest the Federal Reserve will continue to pause on raising rates

Via MarketBeat

Topics Economy Stocks

Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment

November 30, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Pharma is the way to play the re-rise of generic drugs

November 28, 2023

Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth

Via MarketBeat

Israel And Hamas Agree To Extend Truce By 2 Days; Elon Musk Wishes For World Peace After Visiting Israel ↗

November 27, 2023

Israel and Hamas extend temporary truce for two more days. US Secretary of State and Elon Musk visit Israel to discuss situation. UN Secretary-General hopes pause allows for increased humanitarian aid...

Via Benzinga

Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday ↗

November 27, 2023

U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday. Shares of Ituran Location and Control Ltd. (NASDAQ: ITRN) gained during Monday’s session after the company...

Via Benzinga

Topics Stocks

CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday ↗

November 27, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

3 Resilient Stocks with Massive Potential to Boost Your Wealth ↗

November 26, 2023

These three stocks with massive potential can make patient investors fabuslously wealthy as they come roaring back to life.

Via InvestorPlace

Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference

November 20, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

2 overlooked stocks that crushed earnings but traded lower

November 20, 2023

As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results

Via MarketBeat

Resilient Large Cap Israeli- Domiciled U.S. Exchange-Listed Stocks Up 16.5% Last Week ↗

November 19, 2023

After an unsurprising drop at the beginning of the war, the 15 large-cap Israeli- domiciled companies listed on U.S. stock exchanges have bounced back and are now up 1.2%, on average, since Oct.7....

Via Talk Markets

Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.

November 17, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Tuesday Talk: What's Going On? ↗

November 14, 2023

The stock market rallied last week. The S&P 500 closed 51 points higher, the Dow closed 191 points higher, and the Nasdaq Composite closed 284 points higher. But is the rally real?

Via Talk Markets

Topics Stocks

Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program

November 13, 2023

From Royalty Pharma plc

Via GlobeNewswire

Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program

November 13, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Israel-Hamas War News: Top 15 Israeli-Based US-Traded Stocks Continue To Slide ↗

November 12, 2023

The Israel-Hamas War is adversely affecting everything in Israel, including the stock performances of the 15 Israeli companies with market capitalizations of $2B or more that are listed on the Nasdaq...

Via Talk Markets

Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript ↗

November 08, 2023

TEVA earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Teva Pharmaceutical Lifts Revenue Forecast - Huntington's And Migraine Drugs Help Q3 Performance ↗

November 08, 2023

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported Q3 sales of $3.85 billion, beating the consensus of $3.72 billion

Via Benzinga

Teva Closes In On A Buy Point On Third-Quarter Beat, Business Separation ↗

November 08, 2023

The company named a new chief executive for its Teva api business.

Via Investor's Business Daily

US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings ↗

November 08, 2023

Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into...

Via Benzinga

Topics Economy

Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance

November 08, 2023

From Teva Pharmaceutical Industries Limited

Via Business Wire

Earnings Scheduled For November 8, 2023 ↗

November 08, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Via Benzinga

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.